Diagnosis and treatment of deep-vein thrombosis
Open Access
- 24 October 2006
- journal article
- review article
- Published by CMA Impact Inc. in CMAJ : Canadian Medical Association Journal
- Vol. 175 (9), 1087-1092
- https://doi.org/10.1503/cmaj.060366
Abstract
Deep-vein thrombosis (DVT) is a common condition that can lead to complications such as postphlebitic syndrome, pulmonary embolism and death. The approach to the diagnosis of DVT has evolved over the years. Currently an algorithm strategy combining pretest probability, D-dimer testing and compression ultrasound imaging allows for safe and convenient investigation of suspected lower-extremity thrombosis. Patients with low pretest probability and a negative D-dimer test result can have proximal DVT excluded without the need for diagnostic imaging. The mainstay of treatment of DVT is anticoagulation therapy, whereas interventions such as thrombolysis and placement of inferior vena cava filters are reserved for special situations. The use of low-molecular-weight heparin allows for outpatient management of most patients with DVT. The duration of anticoagulation therapy depends on whether the primary event was idiopathic or secondary to a transient risk factor. More research is required to optimally define the factors that predict an increased risk of recurrent DVT to determine which patients can benefit from extended anticoagulant therapy.Keywords
This publication has 62 references indexed in Scilit:
- Relation between quality of anticoagulant treatment and the development of the postthrombotic syndromeJournal of Thrombosis and Haemostasis, 2005
- Low molecular weight heparin in pregnancy: current issuesBritish Journal of Haematology, 2005
- The Epidemiology of Venous ThromboembolismCirculation, 2003
- Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosisBlood, 2002
- Once versus twice daily LMWH for the initial treatment of venous thromboembolismPublished by Wiley ,2002
- Effect of Patient Weight on the Anticoagulant Response to Adjusted Therapeutic Dosage of Low-Molecular- Weight Heparin for the Treatment ofVenous ThromboembolismPathophysiology of Haemostasis and Thrombosis, 2001
- High Plasma Levels of Factor VIII and the Risk of Recurrent Venous ThromboembolismNew England Journal of Medicine, 2000
- The Risk of Recurrent Deep Venous Thrombosis among Heterozygous Carriers of Both Factor V Leiden and the G20210A Prothrombin MutationNew England Journal of Medicine, 1999
- Long-term outcomes after deep venous thrombosis of the lower extremitiesVascular Medicine, 1998
- Different Intensities of Oral Anticoagulant Therapy in the Treatment of Proximal-Vein ThrombosisNew England Journal of Medicine, 1982